Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

    Study early immune system development from utero through childhood, focusing on HIV/ART exposure in neonates to adolescents, exploring immune cell mechanisms and systemic immunity.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000

    Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV AIDS Research (U42 Clinical Trial Not Allowed)

    This grant funds development and integration of human-based research methods and supports high-quality animal models to advance HIV/AIDS research while reducing animal use where possible.

    HHS-NIH11Forecasted Jan 25, 2027$2,725,311Forecasted

    Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV

    This grant supports research to identify and validate new, modifiable therapeutic targets for improving central nervous system outcomes in people with HIV using patient data and innovative models.

    HHS-NIH11Due Oct 28, 2027

    Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

    Utilize NICHD network infrastructure for innovative clinical trials on women, children, pregnant/lactating, and persons with disabilities.

    HHS-NIH11Due Nov 13, 2026· 17d$6,250,000

    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

    NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.

    HHS-NIH11Due Feb 16, 2027$275,000